- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02681718
Controlling Hyperglycemia Among Minority Population (CHAMP)
24. januar 2018 oppdatert av: Sinai Health System
Controlling Hyperglycemia Among Minority Population (CHAMP): A Randomized Controlled Trial of Two Diabetes Interventions for Underserved Communities
The purpose of this study is to compare the efficacy of three approaches in diabetes management: (1) community health worker (CHW) education; (2) text messaging; and (3) usual hospital-based care.
The goal is to determine the most cost-effective method of diabetes management among an economically-disadvantaged, minority population.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The CHAMP study will test the efficacy of two interventions designed to decrease uncontrolled hyperglycemia (defined as Hemoglobin-A1C (A1C) at or above 9%) among adults with diabetes.
Patients from a safety-net hospital will be randomized into three groups: 1) a control group, 2) an intervention providing diabetes self-care text messages, or 3) an intervention using community health workers to provide diabetes education and linkage to care.
Secondary objectives include increasing diabetes knowledge, improving diabetes self-management, and increasing use of primary care (i.e., make one visit to the physician in 6 months) among the intervention participants.
A cost-effectiveness analysis will determine the most appropriate way to reduce the burden of uncontrolled diabetes.
Studietype
Intervensjonell
Registrering (Faktiske)
272
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60608
- Mount Sinai Hospital
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år til 64 år (Voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
*Hyperglycemia with A1C ≥9%
Exclusion Criteria:
- Lives greater than 20 miles driving distance from Mount Sinai Hospital
- Pregnant women with gestational diabetes
- Advanced end-organ complications due to diabetes that include: end-stage renal disease, stroke with paresis, Congestive Heart Failure (NYHA class III or IV), or other major end-organ complication of diabetes
- Receiving treatment for a major psychiatric disorder (i.e. schizophrenia)
- Unable to understand and give informed consent in either English or Spanish
- Currently or previously participated in a diabetes research study
- Family member currently enrolled in a diabetes research study
- Previously received diabetes care related cell phone text messages
- Unable to receive text messages 3-4 times per week
- Living in a homeless shelter or temporary housing
- Plans to travel outside of the United States for more than 3 months in next year
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Community Health Worker education
During a six-month intervention period, the CHWs will conduct six home-based visitations and provide individualized diabetes education using an intensive diabetes lifestyle curriculum called Diabetes Learning Circle (DLC), developed and used by the Sinai Diabetes Education Program.
At each visit, lasting for approximately one hour, the participants will be motivated to set SMART behavioral goals for diabetes self-management.
At each visit after the initial visit, CHWs will follow-up with each participant to check their progress on their behavioral SMART goals.
In addition, the CHWs will conduct intermittent phone calls (at least one monthly) and home visits as needed.
|
Diabetes self-management education by community health workers
|
Eksperimentell: Cell phone text messaging
The participants in the text messaging group will receive weekly text messages through CareMessage.
Each participant will receive 3-4 text messages per week for 6 months.
|
Diabetes self-management education through cell phone text messaging
|
Ingen inngripen: Control
The participants in the control group will receive education as determined by the hospital's diabetes educator, dietitian, physician, or the participant's managed care provider.
No additional education will be provided by the research team.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Difference in Hemoglobin A1C (CHW vs. Control)
Tidsramme: 6 months
|
To assess whether there is a statistically significant difference in HbA1C level between CHW and control groups at 6 months follow-up.
|
6 months
|
Difference in Hemoglobin A1C (Text Message vs. Control)
Tidsramme: 6 months
|
To assess whether there is a statistically significant difference in HbA1C level between text message and control groups at 6 months follow-up.
|
6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Percentage change in diabetes knowledge test scores
Tidsramme: 6 months
|
Michigan Diabetes and Research Center Knowledge test
|
6 months
|
Mean change in diabetes self-efficacy scores
Tidsramme: 6 months
|
Perceived competence in diabetes scale
|
6 months
|
Mean change in diabetes distress scores
Tidsramme: 6 months
|
Problem areas in diabetes (PAID-5) scale
|
6 months
|
Mean change in participants' beliefs about using insulin scores
Tidsramme: 6 months
|
Insulin treatment appraisal (ITAS) scale
|
6 months
|
Mean changes in diabetes self-care activities
Tidsramme: 6 months
|
Diabetes self-care activities include: diet, physical activity, self-monitoring of blood glucose, foot-care, and smoking
|
6 months
|
Percentage of participants who visited a physician due to a diabetes related follow-up
Tidsramme: 6 months
|
Self- reported
|
6 months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. januar 2016
Primær fullføring (Faktiske)
1. september 2017
Studiet fullført (Faktiske)
1. september 2017
Datoer for studieregistrering
Først innsendt
3. februar 2016
Først innsendt som oppfylte QC-kriteriene
11. februar 2016
Først lagt ut (Anslag)
12. februar 2016
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
26. januar 2018
Siste oppdatering sendt inn som oppfylte QC-kriteriene
24. januar 2018
Sist bekreftet
1. januar 2018
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- MSH15-46
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Community health worker education
-
NYU Langone HealthAgency for Healthcare Research and Quality (AHRQ)Har ikke rekruttert ennåType 2 diabetesForente stater
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)Fullført
-
Lawson Health Research InstituteOntario Brain InstituteFullførtEpilepsi, generalisertCanada
-
Stanford UniversityCalifornia Initiative to Advance Precision Medicine; Pacific Cancer Care; The Latino Cancer Institute og andre samarbeidspartnereFullført
-
Federal University of PelotasRekruttering
-
University of Maryland, College ParkFullførtInformasjonsformidling | Evidensbasert folkehelseForente stater
-
Chang Gung University of Science and TechnologyChang Gung Memorial Hospital; National Science and Technology CouncilHar ikke rekruttert ennå
-
Cairo UniversityFullførtOral sykdom | Gingival sykdomEgypt
-
London School of Hygiene and Tropical MedicineMedical Research Council Unit, The Gambia; Nova Scotia Gambia Association... og andre samarbeidspartnereFullført
-
Children's Hospital of PhiladelphiaAktiv, ikke rekrutterendeSukkersyke | Type 1 diabetes mellitus | Overholdelse, pasient | Psykososialt problemForente stater